Evidence map›Paper›PMID 42878762›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Annotation and Dereplication of Peptidic Natural Products (PNPs).

Emma Ricart Altimiras

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emma Ricart AltimirasBroad Institute of MIT and Harvard, Cambridge, MA, USA. emma.ricart89@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptidic natural products (PNPs) represent a structurally diverse class of bioactive compounds with significant pharmaceutical potential. Their characterization using tandem mass spectrometry (MS/MS) is often challenging due to complex fragmentation patterns arising from nonlinear structures, modified residues, and diverse bond types. NRPro is a web-based computational tool designed to facilitate both dereplication and automatic annotation of MS/MS spectra of PNPs. By integrating theoretical fragmentation modeling with database matching and statistical validation, NRPro provides an interactive platform for identifying known compounds and interpreting spectral data. This chapter describes the principles, workflow, and practical use of NRPro, including data preparation, parameter selection, result interpretation, and troubleshooting. Particular attention is given to common pitfalls and best practices to ensure reliable annotation and identification of PNPs.

Indexed as

Biological ProductsComputational BiologyPeptidesSoftwareTandem Mass SpectrometryBiological ProductsPeptidesBioinformaticsDereplicationMass spectrometryMS/MSNatural productsNRProPeptidic natural productsSpectral annotation

Identifiers

PMID42878762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.